Name: CNS Pharmaceuticals
Price range: $

The link you have selected will take you to a site outside CNSPharma.com

CNS Pharmaceuticals does not review or control the content of any non-CNS-Pharmaceuticals site. CNS Pharmaceuticals does not endorse and is not responsible for the accuracy, content, practices, or standards of any non-CNS-Pharmaceuticals sources.

Quarterlies

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Financial Filings

Revised definitive proxy soliciting materials

[Amend] Statement of acquisition of beneficial ownership by individuals

General form for quarterly reports under Section 13 or 15(d)

Current report pursuant to Section 13 or 15(d)

Other definitive proxy statements

Prospectus [Rule 424(b)(5)]

Current report pursuant to Section 13 or 15(d)

Current report pursuant to Section 13 or 15(d)

Notice